Abstract:Non-small cell lung cancer (NSCLC) is the main type of lung cancer with high mortality worldwide. To improve NSCLC therapy, the exploration of molecular mechanisms involved in NSCLC progression and identification of their potential therapy targeting is important. Long noncoding RNAs (lncRNAs) have shown important roles in regulating various tumors progression, including NSCLC. We found lncRNA GHRLOS was decreased in NSCLC cell lines and tissues which correlated with poor prognosis of NSCLC patients. However, the role and underlying mechanisms of lncRNA GHRLOS in NSCLC progression remains elusive. The expression of lncRNA GHRLOS was examined in NSCLC cell lines and biopsy specimens of patients with NSCLC by quantitative real time polymerase chain reaction (qRT-PCR). The effects of GHRLOS on proliferation, invasion and apoptosis of NSCLC cells were determined by both in vitro and in vivo experiments. The interaction between GHRLOS and TP53 was determined by dual-luciferase reporter assay and chromatin immunoprecipitation (ChIP) combined with qRT-PCR analysis. RNA immunoprecipitation (RIP) was conducted to validate the binding between GHRLOS and microRNA-346 (miR-346). Dual-luciferase reporter assays were also carried out to reveal the interaction between miR-346 and the 3’ untranslated region (3’UTR) of adenomatous polyposis coli (APC) mRNA.Our data demonstrated that overexpression of lncRNA GHRLOS suppressed cancer cell proliferation and invasion as well as promoted cell apoptosis by regulating the expression of CDK2, PCNA, E-cadherin, N-cadherin, Bax, and Bcl-2 in NSCLC cells. Moreover, lncRNA GHRLOS was upregulated by the binding of TP53 to the GHRLOS promoter. The binding target of lncRNA GHRLOS was identified to be miR-346. Impressively, overexpression of miR-346 promoted cell proliferation and invasion, as well as inhibited cell apoptosis, however, these effects can be blocked by overexpression of lncRNA GHRLOS both in vitro and in vivo . In summary, this study reveals lncRNA GHRLOS, upregulated by TP53, acts as a molecule sponge of miR-346 to cooperatively modulates expression of APC, a miR-346 target, and potentially inhibits NSCLC progression via TP53/lncRNA GHRLOS/miR-346/APC axis, which represents a novel pathway that could be useful in targeted therapy against NSCLC.

LncRNA TP53TG1 Plays an Anti-Oncogenic Role in Cervical Cancer by Synthetically Regulating Transcriptome Profile in HeLa Cells.

Identification Of The Long Non-Coding Rna Let As A Novel Tumor Suppressor In Gastric Cancer

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Long Noncoding Rna Tp53tg1 Suppresses The Growth And Metastasis Of Hepatocellular Carcinoma By Regulating The Prdx4/Beta-Catenin Pathway

Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway

Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer Through Upregulation of TBL1XR1 Expression.

M6a Modification-Mediated Lncrna TP53TG1 Inhibits Gastric Cancer Progression by Regulating CIP2A Stability.

Long Non‑coding RNA AK001903 Regulates Tumor Progression in Cervical Cancer

Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation

Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p

The Long Non-coding RNA LINC01705 Regulates the Development of Breast Cancer by Sponging miR-186-5p to Mediate TPR Expression as a Competitive Endogenous RNA

TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis

Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration

LncRNA SFTA1P Promotes Cervical Cancer Progression by Interaction with PTBP1 to Facilitate TPM4 Mrna Degradation

Lncrna Mt1jp Functions As A Tumor Suppressor by Interacting with Tiar to Modulate the P53 Pathway

Long Non-Coding RNA in Cervical Cancer: from Biology to Therapeutic Opportunity

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma

P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer

LncRNA PCAT-1 Regulates the Proliferation, Metastasis and Invasion of Cervical Cancer Cells

Identification of Lncrnas by Microarray Analysis Reveals the Potential Role of Lncrnas in Cervical Cancer Pathogenesis

LncRNA RSU1P2 Contributes to Tumorigenesis by Acting As a Cerna Against Let-7A in Cervical Cancer Cells.